Page All:
Page 1
Elsevier Introduces SciVerse Scopus Alerts Individual
AMSTERDAM, October 6, 2011/PRNewswire-FirstCall/ --
Mobile app now also available to non-institutional subscribers
Elsevier, a world-leading provider of scientific, technical and medical
information products and services, today announced the availability of a new
mobile application, SciVerse Scopus Alerts Individual, which provides
non-institutional subscribers with immediate, on-the-go access to the latest
Scopus content. While users based in subscribing institutions can already
benefit from a free mobile app, this new service signifies an important
increase in the range and flexibility of Scopus.
Through this new iPhone and Android application, individuals can now
utilize key features of the world's largest abstract and citation database.
SciVerse Scopus Alerts Individual gives users the opportunity to search
across thousands of scholarly journals from more than 5,000 international
publishers. This is the first time Elsevier has offered any form of
individual subscription to its flagship bibliographic database.
Among the key features of SciVerse Scopus Alerts Individual is the
search and citation alerts function, which allows researchers to receive
updates on new publications relevant to their fields of interest and
notifications on citations of their work by peers. The mobile application
also fosters collaboration among the research community as users can share
links to articles with colleagues through an email function included in the
app.
"For those who wish to stay connected in today's competitive research
landscape, leaving their work at the lab is no longer an option," said Yukun
Harsono, Senior Vice President, Search & Discovery at Elsevier. "By
broadening the availability of Scopus through a mobile application to
individuals who do not receive subscriptions through their institutions
already, more researchers and librarians are able to keep their work at
their fingertips, wherever their work takes them."
SciVerse Scopus Alerts Individual is available to non-institutional
subscribers for a 30-day free trial and subsequently a yearly fee. It is
available globally through the iTunes store
[http://itunes.apple.com/app/sciverse-scopus-alerts-individual/id417735089?mt=8 ]
and for Android devices through AndroidMarket
[https://market.android.com/details?id=com.service2media.Scopus&feature=search_result ]
.
For existing institutional subscribers the free SciVerse Scopus Alerts
App [http://www.info.sciverse.com/sciverse-mobile-applications/overview ]
for iPhone, Android or Blackberry will remain available.
For more information on SciVerse Mobile Applications, go to
http://www.info.sciverse.com/sciverse-mobile-applications.
About SciVerse Scopus
Covering the world's research literature, SciVerse Scopus (
http://www.info.sciverse.com/scopus) is the largest abstract and
citation database of peer-reviewed literature and quality Web sources with
smart tools to track analyze and visualize research. SciVerse Scopus was
designed and developed with over 500 users and librarians internationally.
Its unique database contains abstracts and references from nearly 18,000
peer-reviewed journals from 5,000 publishers worldwide, ensuring broad
interdisciplinary coverage. In addition, SciVerse Scopus not only offers
users citation information about the articles covered, but also directly
integrates Web and patent searches. Direct links to full-text articles,
library resources and other applications like reference management software,
make SciVerse Scopus quicker, easier and more comprehensive to use than any
other literature research tool.
About Elsevier
Elsevier is a world-leading provider of scientific, technical and medical
information products and services. The company works in partnership with the
global science and health communities to publish more than 2,000 journals,
including The Lancet [http://www.thelancet.com ] and Cell
[http://www.cell.com ], and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier's online solutions include
SciVerse ScienceDirect [http://www.sciencedirect.com ], SciVerse Scopus
[http://www.scopus.com ], Reaxys [http://www.reaxys.com ], MD Consult
[http://www.mdconsult.com ] and Nursing Consult
[http://www.nursingconsult.com ], which enhance the productivity of science
and health professionals, and the SciVal suite [http://www.scival.com ] and
MEDai's Pinpoint Review [http://www.medai.com ], which help research and
health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier
[http://www.elsevier.com ] employs 7,000 people worldwide. The company is
part of Reed Elsevier Group PLC [http://www.reedelsevier.com ], a
world-leading publisher and information provider, which is jointly owned by
Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext
Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock
Exchange).
Media contact
Sandra Plasse
+1-212-752-8338
splasse@psbpr.com
Source: Elsevier
.
Elsevier Introduces SciVerse Scopus Alerts Individual
AMSTERDAM, October 6, 2011/PRNewswire-FirstCall/ --
Mobile app now also available to non-institutional subscribers
Elsevier, a world-leading provider of scientific, technical and medical
information products and services, today announced the availability of a new
mobile application, SciVerse Scopus Alerts Individual, which provides
non-institutional subscribers with immediate, on-the-go access to the latest
Scopus content. While users based in subscribing institutions can already
benefit from a free mobile app, this new service signifies an important
increase in the range and flexibility of Scopus.
Through this new iPhone and Android application, individuals can now
utilize key features of the world's largest abstract and citation database.
SciVerse Scopus Alerts Individual gives users the opportunity to search
across thousands of scholarly journals from more than 5,000 international
publishers. This is the first time Elsevier has offered any form of
individual subscription to its flagship bibliographic database.
Among the key features of SciVerse Scopus Alerts Individual is the
search and citation alerts function, which allows researchers to receive
updates on new publications relevant to their fields of interest and
notifications on citations of their work by peers. The mobile application
also fosters collaboration among the research community as users can share
links to articles with colleagues through an email function included in the
app.
"For those who wish to stay connected in today's competitive research
landscape, leaving their work at the lab is no longer an option," said Yukun
Harsono, Senior Vice President, Search & Discovery at Elsevier. "By
broadening the availability of Scopus through a mobile application to
individuals who do not receive subscriptions through their institutions
already, more researchers and librarians are able to keep their work at
their fingertips, wherever their work takes them."
SciVerse Scopus Alerts Individual is available to non-institutional
subscribers for a 30-day free trial and subsequently a yearly fee. It is
available globally through the iTunes store
[http://itunes.apple.com/app/sciverse-scopus-alerts-individual/id417735089?mt=8 ]
and for Android devices through AndroidMarket
[https://market.android.com/details?id=com.service2media.Scopus&feature=search_result ]
.
For existing institutional subscribers the free SciVerse Scopus Alerts
App [http://www.info.sciverse.com/sciverse-mobile-applications/overview ]
for iPhone, Android or Blackberry will remain available.
For more information on SciVerse Mobile Applications, go to
http://www.info.sciverse.com/sciverse-mobile-applications.
About SciVerse Scopus
Covering the world's research literature, SciVerse Scopus (
http://www.info.sciverse.com/scopus) is the largest abstract and
citation database of peer-reviewed literature and quality Web sources with
smart tools to track analyze and visualize research. SciVerse Scopus was
designed and developed with over 500 users and librarians internationally.
Its unique database contains abstracts and references from nearly 18,000
peer-reviewed journals from 5,000 publishers worldwide, ensuring broad
interdisciplinary coverage. In addition, SciVerse Scopus not only offers
users citation information about the articles covered, but also directly
integrates Web and patent searches. Direct links to full-text articles,
library resources and other applications like reference management software,
make SciVerse Scopus quicker, easier and more comprehensive to use than any
other literature research tool.
About Elsevier
Elsevier is a world-leading provider of scientific, technical and medical
information products and services. The company works in partnership with the
global science and health communities to publish more than 2,000 journals,
including The Lancet [http://www.thelancet.com ] and Cell
[http://www.cell.com ], and close to 20,000 book titles, including major
reference works from Mosby and Saunders. Elsevier's online solutions include
SciVerse ScienceDirect [http://www.sciencedirect.com ], SciVerse Scopus
[http://www.scopus.com ], Reaxys [http://www.reaxys.com ], MD Consult
[http://www.mdconsult.com ] and Nursing Consult
[http://www.nursingconsult.com ], which enhance the productivity of science
and health professionals, and the SciVal suite [http://www.scival.com ] and
MEDai's Pinpoint Review [http://www.medai.com ], which help research and
health care institutions deliver better outcomes more cost-effectively.
A global business headquartered in Amsterdam, Elsevier
[http://www.elsevier.com ] employs 7,000 people worldwide. The company is
part of Reed Elsevier Group PLC [http://www.reedelsevier.com ], a
world-leading publisher and information provider, which is jointly owned by
Reed Elsevier PLC and Reed Elsevier NV. The ticker symbols are REN (Euronext
Amsterdam), REL (London Stock Exchange), RUK and ENL (New York Stock
Exchange).
Media contact
Sandra Plasse
+1-212-752-8338
splasse@psbpr.com
Source: Elsevier
.